Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapy
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Nephrology"
DOI: 10.1007/s40620-018-0552-9
Abstract: Clinically apparent venous thromboembolism (VTE) occurs in approximately 7% of patients with membranous nephropathy. Hypoalbuminemia at diagnosis is an independent risk factor for VTE, and risk increases significantly as albumin falls. Optimal prophylactic and treatment… read more here.
Keywords: recurrent venous; venous thromboembolism; membranous nephropathy; inhibitor ... See more keywords
Development of Sex-Stratified Prediction Models for Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study.
Sign Up to like & getrecommendations! Published in 2020 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0040-1708877
Abstract: OBJECTIVE To optimize decision making for anticoagulant treatment duration after incident venous thromboembolism, we derived and internally validated two clinically applicable sex-specific prediction models for venous thromboembolism recurrence, discarding the traditional categorization of provoked and… read more here.
Keywords: recurrent venous; treatment; thromboembolism; venous thromboembolism ... See more keywords
Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non‐recurrent disease
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14402
Abstract: Essentials Venous thromboembolism (VTE) recurrence leads to decreased clot elastic modulus in plasma. Recurrent VTE is not linked to changes in clot structure, fiber radius, or factor XIII activity. Other plasma components may play a… read more here.
Keywords: recurrent venous; venous thromboembolism; elastic modulus;
Factor XI and recurrent venous thrombosis: an observational cohort study
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14415
Abstract: Essentials Factor XI is a potential target for anticoagulation. The association between factor XI and venous thrombosis recurrence was tested in a cohort study. Low factor XI was associated with reduced risk of recurrent venous… read more here.
Keywords: venous thrombosis; recurrent venous; factor; thrombosis ... See more keywords
Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14535
Abstract: Several models are available to predict recurrent venous thrombosis (VT) in patients with unprovoked first events. read more here.
Keywords: venous thrombosis; recurrent venous; prediction recurrent; risk prediction ... See more keywords
Recurrent Venous Thromboembolism in Two Patients With Cancer Taking Rivaroxaban
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Pharmacy Practice"
DOI: 10.1177/0897190016639805
Abstract: Pharmacologic agents for the treatment and prevention of venous thromboembolism in the cancer patient population are limited. Currently, low-molecular-weight heparin is recommended by national consensus guidelines for this indication. Rivaroxaban, an oral factor Xa inhibitor,… read more here.
Keywords: thromboembolism two; recurrent venous; patients cancer; thromboembolism ... See more keywords